Sectra (STO:SECT B) Knows How To Allocate Capital
May 08
Swedish (OMX) Healthcare Sector Analysis
UpdatedMay 29, 2024
DataAggregated Company Financials
Companies187
- 7D1.2%
- 3M10.6%
- 1Y10.3%
- YTD2.9%
Over the last 7 days, the Healthcare industry has risen 1.2%, driven by gains from Calliditas Therapeutics of 74%. This takes the industry's 12 month performance to a gain of 10%. As for the next few years, earnings are expected to grow by 35% per annum.
Sector Valuation and Performance
Has the Swedish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 29 May 2024 | kr556.4b | kr195.9b | -kr2,792,392,543.24 | 36.3x | -199.2x | 2.8x |
| Fri, 26 Apr 2024 | kr547.0b | kr195.2b | -kr3,609,418,549.86 | 44.5x | -151.6x | 2.8x |
| Sun, 24 Mar 2024 | kr519.8b | kr192.7b | -kr3,668,825,382.98 | 43.3x | -141.7x | 2.7x |
| Tue, 20 Feb 2024 | kr517.5b | kr191.7b | -kr4,105,248,032.63 | 49x | -126.1x | 2.7x |
| Thu, 18 Jan 2024 | kr546.4b | kr191.7b | -kr968,025,477.00 | 47.7x | -564.5x | 2.9x |
| Sat, 16 Dec 2023 | kr543.4b | kr191.4b | -kr942,084,132.00 | 50.3x | -576.8x | 2.8x |
| Mon, 13 Nov 2023 | kr470.7b | kr190.3b | -kr1,054,239,686.00 | 49.4x | -446.5x | 2.5x |
| Wed, 11 Oct 2023 | kr450.7b | kr184.9b | -kr2,029,425,074.00 | 34.2x | -222.1x | 2.4x |
| Fri, 08 Sep 2023 | kr454.7b | kr185.7b | -kr2,025,575,303.00 | 36.2x | -224.5x | 2.4x |
| Sun, 06 Aug 2023 | kr473.1b | kr183.9b | -kr1,034,178,130.00 | 39.9x | -457.5x | 2.6x |
| Tue, 04 Jul 2023 | kr474.9b | kr179.3b | -kr795,617,474.00 | 44.8x | -596.9x | 2.6x |
| Thu, 01 Jun 2023 | kr506.4b | kr178.8b | -kr545,224,135.00 | 42.7x | -928.7x | 2.8x |
| Sat, 29 Apr 2023 | kr518.2b | kr175.8b | -kr792,830,499.00 | 35.3x | -653.6x | 2.9x |
| Mon, 27 Mar 2023 | kr482.3b | kr172.4b | -kr1,417,086,752.00 | 35.3x | -340.4x | 2.8x |
| Wed, 22 Feb 2023 | kr497.2b | kr170.0b | -kr579,935,044.00 | 38x | -857.3x | 2.9x |
| Fri, 20 Jan 2023 | kr509.2b | kr165.7b | kr671.6m | 33.1x | 758.2x | 3.1x |
| Sun, 18 Dec 2022 | kr473.1b | kr165.3b | kr708.2m | 32.1x | 668x | 2.9x |
| Tue, 15 Nov 2022 | kr497.7b | kr163.5b | kr950.6m | 31x | 523.6x | 3x |
| Thu, 13 Oct 2022 | kr441.6b | kr159.8b | -kr225,590,028.00 | 27.5x | -1957.4x | 2.8x |
| Sat, 10 Sep 2022 | kr481.9b | kr159.3b | -kr74,884,812.00 | 33.4x | -6435.6x | 3x |
| Mon, 08 Aug 2022 | kr526.5b | kr156.7b | -kr326,683,368.00 | 30.9x | -1611.6x | 3.4x |
| Wed, 06 Jul 2022 | kr515.4b | kr154.1b | kr324.1m | 32x | 1590.2x | 3.3x |
| Fri, 03 Jun 2022 | kr552.5b | kr155.0b | kr396.2m | 36.2x | 1394.6x | 3.6x |
| Sun, 01 May 2022 | kr547.7b | kr150.1b | kr760.1m | 43.2x | 720.6x | 3.6x |
| Tue, 29 Mar 2022 | kr609.9b | kr147.6b | kr1.4b | 43.3x | 447.2x | 4.1x |
| Thu, 24 Feb 2022 | kr578.5b | kr146.7b | kr2.8b | 37.6x | 207.2x | 3.9x |
| Sat, 22 Jan 2022 | kr643.1b | kr144.1b | kr3.5b | 44.8x | 185.5x | 4.5x |
| Mon, 20 Dec 2021 | kr720.9b | kr143.8b | kr3.5b | 50x | 207x | 5x |
| Wed, 17 Nov 2021 | kr789.4b | kr149.3b | kr1.2b | 52.4x | 648.1x | 5.3x |
| Fri, 15 Oct 2021 | kr738.2b | kr140.2b | kr4.1b | 55.4x | 181.8x | 5.3x |
| Sun, 12 Sep 2021 | kr795.7b | kr140.4b | kr4.1b | 59.3x | 193.4x | 5.7x |
| Tue, 10 Aug 2021 | kr744.9b | kr140.4b | kr4.4b | 55.6x | 167.6x | 5.3x |
Price to Earnings Ratio
293.1x
Current Industry PE
- Investors are pessimistic on the Swedish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 3.5x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
- Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 13% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare sector?
| SE Market | -0.60% | |
| Healthcare | 1.24% | |
| Pharma | 8.52% | |
| Life Sciences | 1.38% | |
| Medical Equipment | 1.04% | |
| Healthtech | 0.24% | |
| Biotech | 0.099% | |
| Healthcare Services | -0.70% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 312x.
- Analysts are expecting annual earnings growth of 18.0%, which is lower than the prior year's growth of 192.2% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 53% over the next 5 years.
- However this is lower than its past earnings growth rate of 132% per year.
- In contrast, the Healthtech industry is expected to see its earnings grow by 18% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CALTX Calliditas Therapeutics | kr202.40 | 77.5% +kr4.7b | 120.2% | PS9x | |
| GETI B Getinge | kr191.45 | 3.1% +kr1.6b | -23.3% | PE22.8x | |
| BIOA B BioArctic | kr232.60 | 4.3% +kr847.9m | -27.1% | PS81.5x | |
| SECT B Sectra | kr240.20 | 1.4% +kr655.1m | 30.5% | PE109x | |
| AMBEA Ambea | kr71.60 | 8.6% +kr489.1m | 105.9% | PE12.5x |